The Interconnection Between Immuno-Metabolism, Diabetes, and CKD

Area of Science:

• Immunology
• Metabolic disease
• Nephrology

Background:

• Metabolic reprogramming is a key feature of immune cell activation.
• Immuno-metabolism describes the interplay between cellular metabolism and immune function.

Purpose of the Study:

• To review the link between immuno-metabolism, diabetes, and diabetic nephropathy.
• To explore how metabolic dysregulation impacts immune responses in diabetes.

Main Methods:

• Literature review of immuno-metabolism, diabetes, and diabetic nephropathy.
• Analysis of the effects of hyperglycemia and dyslipidemia on inflammation.
• Examination of the impact of diabetes treatments on immuno-inflammatory responses.

Main Results:

• Increased glucose, triglycerides, and free fatty acids promote low-grade inflammation and immune suppression.
• This "apparent paradox" accelerates end-stage renal disease (ESRD) progression and increases mortality.
• Diabetes treatments may offer benefits beyond glucose control by modulating immuno-inflammatory pathways.

Conclusions:

• Hyperglycemia and dyslipidemia exacerbate immuno-inflammatory responses, worsening metabolic diseases and kidney disease.
• Targeting cellular checkpoints in immune cell metabolism offers novel therapeutic strategies for diabetic complications.